1. Nin JW,et al. Higher plasma soluble receptor for advanced glycation
endproducts (sRAGE) levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-yr follow-up study. Diabetes. 2010 Jun 3. [Epub ahead of print]
2. Yamagishi S, Matsui T. Soluble form of a receptor for advanced glycation end products (sRAGE) as a biomarker. Front Biosci (Elite Ed). 2010 Jun 1;2:1184-95.
3. Shang L, et al. RAGE modulates hypoxia/reoxygenation injury in adult murine cardiomyocytes via JNK and GSK-3beta signaling pathways. PLoS One. 2010 Apr 9;5(4):e10092.
4. Krechler T, et al. Soluble receptor for advanced glycation end-products (sRAGE) and polymorphisms of RAGE and glyoxalase I genes in patients with pancreas cancer. Clin Biochem. 2010 Jul;43(10-11):882-6. Epub 2010 Apr 14.